Taking Breast Cancer Prevention Drug Beyond 5 Years May Not Raise Survival

WEDNESDAY, Dec. 7, 2016 — Many breast cancer survivors take anti-estrogen drugs for at least five years to help lessen their risk of recurrence.
Now, new research suggests that taking such a drug for an even longer period might not confer any added…
Source: Topamax